151 related articles for article (PubMed ID: 9096809)
1. LDL apheresis with dextran sulfate and angiotension receptor antagonist (Losartan).
Elicio N; Bertolini S; Garbarini R; Nardiello G; Elicio A; Aimale V
Artif Organs; 1997 Apr; 21(4):334-5. PubMed ID: 9096809
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.
Pitt B; Chang P; Timmermans PB
Cardiovasc Drugs Ther; 1995 Oct; 9(5):693-700. PubMed ID: 8573552
[TBL] [Abstract][Full Text] [Related]
3. Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis.
Kojima S; Shida M; Takano H; Inami S; Yodogawa K; Yokoyama H; Kuramochi M
Hypertens Res; 2001 Sep; 24(5):595-8. PubMed ID: 11675956
[TBL] [Abstract][Full Text] [Related]
4. LDL-apheresis with dextran sulphate and anaphylactoid reactions to ACE inhibitors.
Keller C; Grützmacher P; Bahr F; Schwarzbeck A; Kroon AA; Kiral A
Lancet; 1993 Jan; 341(8836):60-1. PubMed ID: 8093314
[No Abstract] [Full Text] [Related]
5. Antiproteinuric effect of Losartan in patients with chronic renal diseases.
Zoccali C; Valvo E; Russo D; Panichi V; Zuccala' A
Nephrol Dial Transplant; 1997 Jan; 12(1):234-5. PubMed ID: 9027813
[No Abstract] [Full Text] [Related]
6. Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril.
Rodrigo E; Maeso R; Muñoz-García R; Navarro-Cid J; Ruilope LM; Cachofeiro V; Lahera V
J Hypertens; 1997 Jun; 15(6):613-8. PubMed ID: 9218180
[TBL] [Abstract][Full Text] [Related]
7. An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.
Byyny RL; Merrill DD; Bradstreet TE; Sweet CS
Cardiovasc Drugs Ther; 1996 Jul; 10(3):313-9. PubMed ID: 8877074
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin receptor antagonists.
Goldsmith DJ
Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
[No Abstract] [Full Text] [Related]
9. The angiotensin II type 1 receptor blocker losartan in clinical practice: a review.
Gavras HP; Salerno CM
Clin Ther; 1996; 18(6):1058-67; discussion 1057. PubMed ID: 9001823
[TBL] [Abstract][Full Text] [Related]
10. [Dosage equivalents of AT1-receptor antagonists available in Germany].
Dominiak P; Häuser W
Dtsch Med Wochenschr; 2003 Oct; 128(44):2315-8. PubMed ID: 14593575
[No Abstract] [Full Text] [Related]
11. Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease.
Burrell LM; Johnston CI
Drugs Aging; 1997 Jun; 10(6):421-34. PubMed ID: 9205848
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
Goldberg AI; Dunlay MC; Sweet CS
Am J Cardiol; 1995 Apr; 75(12):793-5. PubMed ID: 7717281
[TBL] [Abstract][Full Text] [Related]
13. [Fast-acting sartan. High blood pressure therapy without long waiting time].
MMW Fortschr Med; 2003 Jun; 145(24):55. PubMed ID: 12866306
[No Abstract] [Full Text] [Related]
14. Clinical experience with angiotensin II receptor antagonists.
Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J
Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619
[TBL] [Abstract][Full Text] [Related]
15. Angioedema of the intestine.
Gabb GM
N Engl J Med; 1996 Nov; 335(20):1534-5; author reply 1535. PubMed ID: 8927095
[No Abstract] [Full Text] [Related]
16. Angioedema associated with angiotensin II receptor antagonist losartan.
Sharma PK; Yium JJ
South Med J; 1997 May; 90(5):552-3. PubMed ID: 9160080
[TBL] [Abstract][Full Text] [Related]
17. ACE inhibitors and LDL-apheresis with dextran sulphate adsorption.
Kroon AA; Mol MJ; Stalenhoef AF
Lancet; 1992 Dec; 340(8833):1476. PubMed ID: 1360599
[No Abstract] [Full Text] [Related]
18. Comparative effects of combination drug therapy regimens commencing with either losartan potassium, an angiotensin II receptor antagonist, or enalapril maleate for the treatment of severe hypertension.
Ruff D; Gazdick LP; Berman R; Goldberg AI; Sweet CS
J Hypertens; 1996 Feb; 14(2):263-70. PubMed ID: 8728306
[TBL] [Abstract][Full Text] [Related]
19. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy].
Krasnikova TL
Klin Med (Mosk); 1996; 74(3):17-21. PubMed ID: 8926692
[No Abstract] [Full Text] [Related]
20. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
Lacourcière Y
Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
